⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BNGO News
Bionano Genomics, Inc. Common Stock
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
globenewswire.com
BNGO
Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress
globenewswire.com
BNGO
Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia
globenewswire.com
BNGO
Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025
globenewswire.com
BNGO
Bionano to Participate in the H.C. Wainwright @ Home Event
globenewswire.com
BNGO